{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:13:40Z","timestamp":1791198820666,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,9]],"date-time":"2015-10-09T00:00:00Z","timestamp":1444348800000},"content-version":"vor","delay-in-days":465,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["cancercell.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.ccr.2014.05.002","type":"journal-article","created":{"date-parts":[[2014,7,14]],"date-time":"2014-07-14T11:46:35Z","timestamp":1405338395000},"page":"77-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":273,"title":["Hematogenous Metastasis of Ovarian Cancer: Rethinking Mode of Spread"],"prefix":"10.1016","volume":"26","author":[{"given":"Sunila","family":"Pradeep","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung\u00a0W.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry\u00a0Y.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"Chaluvally-Raghavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahito","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad\u00a0V.","family":"Pecot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun\u00a0Jin","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farideh\u00a0Z.","family":"Bischoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie\u00a0Ann","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpa\u00a0M.","family":"Nick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn\u00a0S.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Rodriguez-Aguayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behrouz","family":"Zand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather\u00a0J.","family":"Dalton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiruvengadam","family":"Arumugam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho\u00a0Jeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee\u00a0Dong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min\u00a0Soon","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesha","family":"Rupaimoole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingegowda\u00a0S.","family":"Mangala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasudha","family":"Sehgal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang\u00a0Cheul","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Seog","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert\u00a0L.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prahlad","family":"Ram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Lopez-Berestein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaiah\u00a0J.","family":"Fidler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil\u00a0K.","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccr.2014.05.002_bib1","doi-asserted-by":"crossref","first-page":"28238","DOI":"10.1074\/jbc.273.43.28238","article-title":"Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via phosphatidylinositol-3 kinase","volume":"273","author":"Adam","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ccr.2014.05.002_bib2","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1200\/JCO.2012.42.0505","article-title":"OCEANS: A randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer","volume":"30","author":"Aghajanian","year":"2012","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccr.2014.05.002_bib3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ccr.2010.06.018","article-title":"SIK2 is a centrosome kinase required for bipolar mitotic spindle formation that provides a potential target for therapy in ovarian cancer","volume":"18","author":"Ahmed","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccr.2014.05.002_bib4","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1148\/radiol.2482070371","article-title":"Perihepatic metastases from ovarian cancer: Sensitivity and specificity of CT for the detection of metastases with and those without liver parenchymal invasion","volume":"248","author":"Akin","year":"2008","journal-title":"Radiology"},{"key":"10.1016\/j.ccr.2014.05.002_bib5","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1517\/14712598.2010.512003","article-title":"HER3 mRNA as a predictive biomarker in anticancer therapy","volume":"10","author":"Amler","year":"2010","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.ccr.2014.05.002_bib6","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ygyno.2003.12.041","article-title":"Expression of platelet-derived growth factor and activated receptor in clinical specimens of epithelial ovarian cancer and ovarian carcinoma cell lines","volume":"93","author":"Apte","year":"2004","journal-title":"Gynecol. Oncol."},{"issue":"Suppl 8","key":"10.1016\/j.ccr.2014.05.002_bib7","doi-asserted-by":"crossref","first-page":"viii65","DOI":"10.1093\/annonc\/mdr529","article-title":"Antiangiogenic agents should be integrated into the standard treatment for patients with ovarian cancer","volume":"22","author":"Burger","year":"2011","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ccr.2014.05.002_bib8","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2014.05.002_bib9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.canrad.2005.03.001","article-title":"[Ovarian metastasis and lung adenocarcinoma: A case report]","volume":"9","author":"Castadot","year":"2005","journal-title":"Cancer Radiother."},{"key":"10.1016\/j.ccr.2014.05.002_bib10","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1200\/JCO.2005.05.4221","article-title":"Clinical activity of pertuzumab (rhuMAb 2C4), a HER dimerization inhibitor, in advanced ovarian cancer: Potential predictive relationship with tumor HER2 activation status","volume":"24","author":"Gordon","year":"2006","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccr.2014.05.002_bib11","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1158\/1078-0432.CCR-10-0005","article-title":"Targeted gene silencing using RGD-labeled chitosan nanoparticles","volume":"16","author":"Han","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"Suppl 1","key":"10.1016\/j.ccr.2014.05.002_bib12","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1016\/S0020-7292(06)60033-7","article-title":"Carcinoma of the ovary. FIGO 26th Annual report on the results of treatment in gynecological cancer","volume":"95","author":"Heintz","year":"2006","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ccr.2014.05.002_bib13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1479-5876-9-64","article-title":"Inhibition of phosphorylated c-Met in\u00a0rhabdomyosarcoma cell lines by a small molecule inhibitor SU11274","volume":"9","author":"Hou","year":"2011","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.ccr.2014.05.002_bib14","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.2353\/ajpath.2009.080819","article-title":"Circulating monocytes expressing CD31: Implications for acute and chronic angiogenesis","volume":"174","author":"Kim","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ccr.2014.05.002_bib15","doi-asserted-by":"crossref","first-page":"e1000889","DOI":"10.1371\/journal.pcbi.1000889","article-title":"Use of data-biased random walks on graphs for the retrieval of context-specific networks from genomic data","volume":"6","author":"Komurov","year":"2010","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.ccr.2014.05.002_bib16","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/1471-2164-13-282","article-title":"NetWalker: A contextual network analysis tool for functional genomics","volume":"13","author":"Komurov","year":"2012","journal-title":"BMC Genomics"},{"key":"10.1016\/j.ccr.2014.05.002_bib17","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/msb.2012.25","article-title":"The glucose-deprivation network counteracts lapatinib-induced toxicity in resistant ErbB2-positive breast cancer cells","volume":"8","author":"Komurov","year":"2012","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.ccr.2014.05.002_bib18","doi-asserted-by":"crossref","first-page":"6910","DOI":"10.1158\/0008-5472.CAN-05-0530","article-title":"Therapeutic EphA2 gene targeting in\u00a0vivo using neutral liposomal small interfering RNA delivery","volume":"65","author":"Landen","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccr.2014.05.002_bib19","unstructured":"Ledermann, J.A., Perren, T., Raja1, F.A., Embleton, A. C., Rustin, G.J.S., Jayson, G., Kaye, S.B., Swart, A., Vaughan, M., and Hirte, H. (2013). Randomised double-blind phase III trial of cediranib (AZD 2171) in relapsed platinum sensitive ovarian cancer: Results of the ICON6 trial. http:\/\/conference.ncri.org.uk\/abstracts\/2013\/abstracts\/ClinicalShowcase4.html."},{"key":"10.1016\/j.ccr.2014.05.002_bib20","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.1158\/1078-0432.CCR-11-3250","article-title":"Metronomic activity of CD44-targeted hyaluronic acid-paclitaxel in ovarian carcinoma","volume":"18","author":"Lee","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccr.2014.05.002_bib21","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ygyno.2008.09.046","article-title":"The clinical significance of hepatic parenchymal metastasis in patients with primary epithelial ovarian cancer","volume":"112","author":"Lim","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ccr.2014.05.002_bib22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ccr.2010.06.016","article-title":"Regulation of tumor angiogenesis by EZH2","volume":"18","author":"Lu","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccr.2014.05.002_bib23","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1200\/JCO.2005.05.2456","article-title":"Intraperitoneal chemotherapy of ovarian cancer: A review, with a focus on practical aspects of treatment","volume":"24","author":"Markman","year":"2006","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccr.2014.05.002_bib24","first-page":"716","article-title":"Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies","volume":"109","author":"McCarty","year":"1985","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.ccr.2014.05.002_bib25","unstructured":"Merrimack Pharmaceuticals (2013). Merrimack Pharmaceuticals Announces Results from a phase 2 study of MM-121 (SAR256212) in combination with\u00a0paclitaxel in patients with platinum-resistant or refractory advanced ovarian cancers. http:\/\/investors.merrimackpharma.com\/releasedetail.cfm?ReleaseID=801512."},{"key":"10.1016\/j.ccr.2014.05.002_bib26","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1056\/NEJMoa0803785","article-title":"Dicer, Drosha, and outcomes in patients with ovarian cancer","volume":"359","author":"Merritt","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccr.2014.05.002_bib27","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nrc1611","article-title":"Ovarian cancer metastasis: Integrating insights from disparate model organisms","volume":"5","author":"Naora","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccr.2014.05.002_bib28","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1158\/2159-8290.CD-11-0215","article-title":"A novel platform for detection of CK+ and CK\u2212 CTCs","volume":"1","author":"Pecot","year":"2011","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ccr.2014.05.002_bib29","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1038\/ncomms3427","article-title":"Tumour angiogenesis regulation by the miR-200 family","volume":"4","author":"Pecot","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccr.2014.05.002_bib30","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1056\/NEJMoa1103799","article-title":"A phase 3 trial of bevacizumab in ovarian cancer","volume":"365","author":"Perren","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccr.2014.05.002_bib31","first-page":"72","article-title":"Optical quantification of\u00a0cellular mass, volume, and density of circulating tumor cells identified in an ovarian cancer patient","volume":"2","author":"Phillips","year":"2012","journal-title":"Front Oncol"},{"key":"10.1016\/j.ccr.2014.05.002_bib32","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1158\/0008-5472.CAN-09-3145","article-title":"An ErbB3 antibody, MM-121, is active in cancers with ligand-dependent activation","volume":"70","author":"Schoeberl","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccr.2014.05.002_bib33","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ygyno.2007.03.042","article-title":"Relationship of estrogen and progesterone receptors to clinical outcome in metastatic endometrial carcinoma: A Gynecologic Oncology Group Study","volume":"106","author":"Singh","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ccr.2014.05.002_bib34","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa1110352","article-title":"Paraneoplastic thrombocytosis in ovarian cancer","volume":"366","author":"Stone","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccr.2014.05.002_bib35","first-page":"3584","article-title":"Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts","volume":"44","author":"Tarin","year":"1984","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccr.2014.05.002_bib36","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.1158\/1078-0432.CCR-03-0589","article-title":"EphA2 expression is associated with aggressive features in ovarian carcinoma","volume":"10","author":"Thaker","year":"2004","journal-title":"Clin. Cancer Res."}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610814001925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610814001925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T12:24:36Z","timestamp":1538396676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610814001925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1535610814001925"],"URL":"https:\/\/doi.org\/10.1016\/j.ccr.2014.05.002","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718490430.793527276","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.718490430.793499682","asserted-by":"object"}]},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hematogenous Metastasis of Ovarian Cancer: Rethinking Mode of Spread","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccr.2014.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}